Category: Latest News

Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens

Posted on by Targeting Phage Therapy
Despite the wide availability of antibiotics, infectious diseases remain a leading cause of death worldwide1. In the absence of new therapies, mortality rates due to untreatable infections are predicted to rise more than tenfold by 2050. Natural products (NPs) made by cultured bacteria have been a major source of clinically useful antibiotics. In spite of…
Posted on February 28, 2018
Read More

More than 200 international attendees are already registered for Phage Therapy & Antibiotic Resistance 2018

Posted on by Targeting Phage Therapy
The 5th World Congress on Targeting Infectious Diseases – Phage Therapy & Antibiotic Resistance will gather more than 200 international attendees coming from industries, start-up and universities working on all infectious diseases related fields.   The audience of Phage Therapy 2018 will be composed by attendees coming from all around the world. Among the participants:…
Posted on February 15, 2018
Read More
Special Session for Industrials: Showcase your Innovations & Perspectives

Special Session for Industrials: Showcase your Innovations & Perspectives

Posted on by Targeting Phage Therapy
You are academic or start-up and you have an extraordinary innovation concerning Phage Therapy? You are industrial and you are looking for a new academic collaboration to develop innovations around Phage? A special session B to B  will be organized during the 5th World congress on Targeting Infectious Diseases which will be held  on May…
Posted on November 10, 2017
Read More

Phages are an effective alternative to the use of antibiotics in aquaculture

Posted on by Targeting Phage Therapy
Therapy with phages, instead of antibiotics, is a highly promising option in aquaculture to control the transfer of bacteria that cause important losses or which may be harmful to consumers. Use of these organisms, which infect and destroy bacteria, would significantly reduce the environmental impact of fish farms, whilst increasing their profitability by lowering mortality…
Posted on November 10, 2017
Read More
Developing phage therapy for lung infections

Developing phage therapy for lung infections

Posted on by Targeting Phage Therapy
Dr. Sandra-Maria Wienhold, from Charité – Universitätsmedizin Berlin, Germany will talk about “Bacteriophage therapy for lung infections: recent scientific advances”  during Targeting Phage & Antibiotic Resistance Congress which will be held at October 2 – 3, 2017 at Florence, Italy. Dr. Sandra-Maria Wienhold, veterinarian and researcher in Prof. Martin Witzenrath´s lab (lunglab.de) at the Charité Universitätsmedizin…
Posted on July 20, 2017
Read More

Development of Infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract: strategic presentation of Targeting Phage & Antibiotic Resistance Conference

Posted on by Targeting Phage Therapy
During Targeting Phage & Antibiotic Resistance Conference 2017, Dr Nzakizwanayo from School of Pharmacy and Biomolecular Sciences, University of Brighton, United Kingdom will talk about “Development of Infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract”. According to Dr Nzakizwanayo: “Indwelling urethral catheters (IUC) are widely used for long-term bladder management but are often…
Posted on July 10, 2017
Read More

Pr Brian Jones will present his study on “Control of catheter associated biofilms through efflux inhibition”

Posted on by Targeting Phage Therapy
Pr Brian Jones, from school of Pharmacy and Biomolecular Sciences, University of Brighton, United Kingdom will present his study on “Control of catheter associated biofilms through efflux inhibition“. According to him: “Proteus mirabilis poses particular problems in the care of individuals undergoing long-term urethral catheterization. This organism forms extensive crystalline biofilm structures on catheter surfaces that…
Posted on July 2, 2017
Read More

How to use lytic bacteriophages in the treatment of biofilm-forming bacteria involved in prosthetic joint infections?

Posted on by Targeting Phage Therapy
Dr. Mariagrazia Di Luca from the Charité – Universitätsmedizin Berlin Hospital, Berlin, Germany was invited to give a presentation during Florence Targeting Phage & Antibiotic Resistance Congress 2017. Her presentation will present the role of the lytic bacteriophages in the treatment of biofilm-forming bacteria involved in prosthetic joint infections. According to Dr Di Luca, the infections…
Posted on July 1, 2017
Read More

New Antibiotic Resistance Genes Found in Soil Microbes

Posted on by Targeting Phage Therapy
Farm soil harbors abundant genes related to antibiotic resistance in microbes, including some that have never been identified in human pathogens, according to a study published Friday (June 16) in Applied and Environmental Microbiology. Researchers identified novel gene products, including peptides and enzymes, that can provide resistance to classes of antibiotics used to combat a…
Posted on June 29, 2017
Read More
New generations of antibiotics for MDR pathogens from old antibiotic classes and new resistance breaker

New generations of antibiotics for MDR pathogens from old antibiotic classes and new resistance breaker

Posted on by Targeting Phage Therapy
Prof. Gian Maria Rossolini from University of Florence, Italy will participate to Targeting Antibiotic Resistance 2017 Congress and will talk about his research on “New generations of antibiotics for MDR pathogens from old antibiotic classes and new resistance breaker”. According to Prof. Rossolini: “The modification of old antibiotic scaffolds and the combination of old antibiotics…
Posted on June 5, 2017
Read More